US Stock MarketDetailed Quotes

BMY Bristol-Myers Squibb

Watchlist
  • 59.670
  • +0.530+0.90%
Close Jan 24 16:00 ET
  • 60.000
  • +0.330+0.55%
Post 20:01 ET
121.02BMarket Cap-16.67P/E (TTM)

About Bristol-Myers Squibb Company

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Company Profile

SymbolBMY
Company NameBristol-Myers Squibb
Listing DateJun 1, 1969
Issue Price40.50
Founded1933
CEODr. Christopher S. Boerner, PhD
MarketNYSE
Employees34100
Fiscal Year Ends12-31
AddressRoute 206 & Province Line Road
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08543
Phone1-609-252-4621
Websitehttp://www.bms.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Christopher S. Boerner, PhD
  • Chairman of the Board and Chief Executive Officer
  • 8.46M
  • Adam Lenkowsky
  • Executive Vice President and Chief Commercialization Officer
  • --
  • Dr. Samit Hirawat, M.D.
  • Executive Vice President, Chief Medical Officer and Head of Development
  • 6.23M
  • Dr. Robert M. Plenge
  • Executive Vice President, Chief Research Officer and Head of Research
  • --
  • Gregory Scott Meyers
  • Executive Vice President, Chief Digital Officer and Chief Technology Officer
  • --
  • David V. Elkins
  • Executive Vice President and Chief Financial Officer
  • 7.17M
  • Amanda Ahn Poole
  • Executive Vice President and Chief Human Resources Officer
  • --
  • Cari Gallman
  • Executive Vice President, Corporate Affairs
  • --
  • Sandra Leung
  • Executive Vice President and General Counsel
  • 5.92M
  • Karin Shanahan
  • Executive Vice President, Global Product Development and Supply
  • --
  • Phil Holzer
  • Senior Vice President and Controller
  • --
  • Lynelle Hoch
  • President, Cell Therapy Organization
  • --
  • Dr. Julia A. Haller, M.D.
  • Independent Director
  • 371.68K
  • Phyllis R. Yale
  • Independent Director
  • 365.00K
  • Derica W. Rice
  • Independent Director
  • 375.00K
  • Dr. Manuel Hidalgo Medina, M.D.,PhD
  • Independent Director
  • 335.00K
  • Peter J. Arduini
  • Independent Director
  • 359.68K
  • Dr. Deepak L. Bhatt, M.D.,M.P.H.
  • Independent Director
  • 329.97K
  • Theodore R. Samuels
  • Lead Independent Director
  • 425.00K
  • Dr. Karen H. Vousden, PhD
  • Independent Director
  • 344.74K
  • Michael R. McMullen
  • Independent Director
  • --
  • Paula A. Price
  • Independent Director
  • 365.00K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
GVS
870976
+29.98%
Hangzhou CNCR-IT
300250
+20.03%
Shanghai Newtouch Software
688590
+20.01%
4
Ucap Cloud Information Technology Co.,Ltd
688228
+20.00%
5
Yangtze Optical Electronic
688143
+20.00%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
China Concept Stocks
Tracking the US-listed Chinese companies.
Discussing
U.S.-China talks spark interest, no more inflation?
🎙️Discussion: 1. How will Trump's China policies affect Chinese assets? 2. Which sectors might benefit as U.S. inflation risks decline? Show More
China Will Adopt a "Moderately Accommodative" Monetary Policy in the Next Year, The First Shift to Easing Since 2011